Morgan Stanley Resumes Amgen (AMGN) at Equalweight, 'we see risk/reward as balanced'
Tweet Send to a Friend
(Updated - October 16, 2023 4:36 PM EDT)
Morgan Stanley analyst Terance Flynn resumes coverage on Amgen (NASDAQ: AMGN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Terance Flynn resumes coverage on Amgen (NASDAQ: AMGN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
